Fabino Enterprises Ltd vs Kobo Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Fabino Enterprises Ltd is ₹ 20.31 as of 27 Apr 15:30 . The P/E Ratio of Fabino Enterprises Ltd is 600 as of March 2023 .The P/E Ratio of Kobo Biotech Ltd is 0 as of March 2023 . The Market Cap of Fabino Enterprises Ltd is ₹ 6.3 crore as of March 2023 .The Market Cap of Kobo Biotech Ltd is ₹ 0 crore as of March 2023 . The Revenue of Fabino Enterprises Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Kobo Biotech Ltd is ₹ 0.02 crore as of Jun '24 . The EBITDA of Fabino Enterprises Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Kobo Biotech Ltd is ₹ -0.32 crore as of Jun '24 . The Net Profit of Fabino Enterprises Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Kobo Biotech Ltd is ₹ -1.33 crore as of Jun '24 . The Dividend Payout of Fabino Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Kobo Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Fabino Enterprises Ltd

Fabino Enterprises Limited is a growing pharmaceutical company promoted by Atul Kumar Jain.
The Company was incorporated as 'Fabino Life Sciences Private Limited' on October 27, 2011 with the Registrar of Companies, Delhi and Haryana.
Subsequently, the Company got converted to Public Limited Company and the name of Company was changed to 'Fabino Life Sciences Limited'.
A fresh Certificate of Incorporation was issued on March 21, 2015 by the Registrar of Companies, Delhi. The Company operate in the business of manufacturing, marketing of pharmaceutical, allopathic, herbal, veterinary, and other consumer products like, packing, trading, etc.
The core business is marketing of pharmaceutical formulation & products in domestic market through its own distribution network and sales force under own brand name, getting Ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc.

About Kobo Biotech Ltd

Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992.
Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited.
The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).Promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu, the Company manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA). The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides. The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US.

FAQs for the comparison of Fabino Enterprises Ltd and Kobo Biotech Ltd

Which company has a larger market capitalization, Fabino Enterprises Ltd or Kobo Biotech Ltd?

Market cap of Fabino Enterprises Ltd is 4 Cr while Market cap of Kobo Biotech Ltd is 6 Cr

What are the key factors driving the stock performance of Fabino Enterprises Ltd and Kobo Biotech Ltd?

The stock performance of Fabino Enterprises Ltd and Kobo Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fabino Enterprises Ltd and Kobo Biotech Ltd?

As of May 4, 2026, the Fabino Enterprises Ltd stock price is INR ₹20.31. On the other hand, Kobo Biotech Ltd stock price is INR ₹2.85.

How do dividend payouts of Fabino Enterprises Ltd and Kobo Biotech Ltd compare?

To compare the dividend payouts of Fabino Enterprises Ltd and Kobo Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.